Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Molecular carcinogenesis [Mol Carcinog] NLMUID: 8811105"" wg kryterium: JN


Tytuł :
Associations between tissue-based CD3+ T-lymphocyte count and colorectal cancer survival in a prospective cohort of older women.
Autorzy :
Oyenuga M; Department of Internal Medicine, SSM St Mary's Hospital, St. Louis, Missouri, USA.; Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA.
Vierkant RA; Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, USA.
Lynch CF; Department of Epidemiology, University of Iowa, Iowa City, Iowa, USA.
Pengo T; University of Minnesota Informatics Institute, University of Minnesota, Minneapolis, Minnesota, USA.
Tillmans LS; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
Cerhan JR; Division of Epidemiology, Mayo Clinic, Rochester, Minnesota, USA.
Church TR; Division of Environmental Health Sciences, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA.
Lazovich D; Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA.; Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, USA.
Anderson KE; Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA.; Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, USA.
Limburg PJ; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Prizment AE; Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA.; Division of Hematology, Oncology, and Transplantation, University of Minnesota Medical School, Minneapolis, Minnesota, USA.; Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, USA.
Pokaż więcej
Źródło :
Molecular carcinogenesis [Mol Carcinog] 2020 Nov 17. Date of Electronic Publication: 2020 Nov 17.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
RNA-seq reveals novel cancer-selective and disease subtype-independent mechanistic targets of withaferin A in human breast cancer cells.
Autorzy :
Hahm ER; Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Kim SH; Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Singh KB; Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Singh SV; Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Pokaż więcej
Źródło :
Molecular carcinogenesis [Mol Carcinog] 2020 Nov 04. Date of Electronic Publication: 2020 Nov 04.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Longitudinal change of metabolite profile and its relation to multiple risk factors for the risk of developing hepatitis B-related hepatocellular carcinoma.
Autorzy :
Huang BY; Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.
Tsai MR; Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.
Hsu JK; Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.
Lin CY; Institute of Environmental and Occupational Health Sciences, College of Public Health, National Taiwan University, Taipei, Taiwan.
Lin CL; Department of Gastroenterology, Ren-Ai Branch, Taipei City Hospital, Taipei, Taiwan.
Hu JT; Liver Center, Cathay General Hospital Medical Center, School of Medicine, Fu-Jen Catholic University College of Medicine, Taipei, Taiwan.
Huang YW; Department of Internal Medicine, Division of Gastroenterology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.; Department of Internal Medicine, Division of Gastroenterology, National Taiwan University College of Medicine, Taipei, Taiwan.
Liu CJ; Department of Internal Medicine, Division of Gastroenterology, National Taiwan University Hospital and Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Wu WJ; Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.
Wu CF; Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.
Sung FY; Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.
Chen PJ; Department of Internal Medicine, Division of Gastroenterology, National Taiwan University Hospital and Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Liang HJ; Institute of Environmental and Occupational Health Sciences, College of Public Health, National Taiwan University, Taipei, Taiwan.
Lin SM; Division of Hepatology, Liver Research Unit, Department of Gastroenterology and Hepatology, College of Medicine, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan.
Yu MW; Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.
Pokaż więcej
Źródło :
Molecular carcinogenesis [Mol Carcinog] 2020 Nov; Vol. 59 (11), pp. 1269-1279. Date of Electronic Publication: 2020 Sep 10.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł :
A genetic variant in the promoter of CD46 is associated with the risk and prognosis of hepatocellular carcinoma.
Autorzy :
Liu F; Department of Liver Surgery, Liver Transplantation Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Luo L; Department of Clinical Immunological Laboratory, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Liu Z; Department of Gastroenterology, The First People's Hospital of Yunnan Province, Kunming, Yunnan, China.
Wu S; Division of Core Facilities, West China Hospital, Sichuan University, Chengdu, China.
Zhang W; Department of Critical Care Medicine, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy, Chengdu, China.
Li Q; Department of Liver Surgery, Liver Transplantation Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Peng Y; Department of Liver Surgery, Liver Transplantation Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Wei Y; Department of Liver Surgery, Liver Transplantation Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Li B; Department of Liver Surgery, Liver Transplantation Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Pokaż więcej
Źródło :
Molecular carcinogenesis [Mol Carcinog] 2020 Nov; Vol. 59 (11), pp. 1243-1255. Date of Electronic Publication: 2020 Sep 01.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł :
Mcl-1 targeting strategies unlock the proapoptotic potential of TRAIL in melanoma cells.
Autorzy :
Sarif Z; Department of Dermatology, Venerology, and Allergology, Skin Cancer Center Charité, Charité-Universitätsmedizin Berlin (University Medical Center Charité), Berlin, Germany.
Tolksdorf B; Department of Applied Biochemistry, Institute of Biotechnology, Technical University of Berlin, Berlin, Germany.
Fechner H; Department of Applied Biochemistry, Institute of Biotechnology, Technical University of Berlin, Berlin, Germany.
Eberle J; Department of Dermatology, Venerology, and Allergology, Skin Cancer Center Charité, Charité-Universitätsmedizin Berlin (University Medical Center Charité), Berlin, Germany.
Pokaż więcej
Źródło :
Molecular carcinogenesis [Mol Carcinog] 2020 Nov; Vol. 59 (11), pp. 1256-1268. Date of Electronic Publication: 2020 Sep 04.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł :
Animal model and bioinformatics analyses suggest the TIMP1/MMP9 axis as a potential biomarker in oral squamous cell carcinoma.
Autorzy :
Xu G; Laboratory Animal Center, Shanxi Medical University, Taiyuan, China.
Wei J; Laboratory Animal Center, Shanxi Medical University, Taiyuan, China.
Huangfu B; Laboratory Animal Center, Shanxi Medical University, Taiyuan, China.; Taiyuan Zoo, Taiyuan, China.
Gao J; Laboratory Animal Center, Shanxi Medical University, Taiyuan, China.
Wang X; Laboratory Animal Center, Shanxi Medical University, Taiyuan, China.
Xiao L; Laboratory Animal Center, Shanxi Medical University, Taiyuan, China.
Xuan R; Laboratory Animal Center, Shanxi Medical University, Taiyuan, China.
Chen Z; Laboratory Animal Center, Shanxi Medical University, Taiyuan, China.
Song G; Laboratory Animal Center, Shanxi Medical University, Taiyuan, China.; Mental Health Hospital affiliated to Shanxi Medical University, Taiyuan, China.
Pokaż więcej
Źródło :
Molecular carcinogenesis [Mol Carcinog] 2020 Nov; Vol. 59 (11), pp. 1302-1316.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł :
Protective role of histone deacetylase 4 from ultraviolet radiation-induced DNA lesions.
Autorzy :
Li S; Department of Forensic Medicine, Xuzhou Medical University, Xuzhou, Jiangsu, China.; Jiangsu Medical Engineering, Research Center of Gene Detection, Xuzhou, Jiangsu, China.
Zhou M; Department of Dermatology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Ze K; Department of Dermatology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Sun X; Institute of Dermatology, Shanghai Academy of Traditional Chinese Medicine, Shanghai, China.
Zhao C; Department of Human Anatomy, Xuzhou Medical University, Xuzhou, Jiangsu, China.
Li Z; Department of Forensic Medicine, Xuzhou Medical University, Xuzhou, Jiangsu, China.; Jiangsu Medical Engineering, Research Center of Gene Detection, Xuzhou, Jiangsu, China.
Lu H; Department of General Surgery, Shaanxi Sengong Hospital, Xi'an, Shaanxi, China.
Jiao Y; Department of Respiratory Medicine, Wenjiang District People's Hospital, Chengdu, China.
Wang T; Department of Computer Science and Information Technology, Austin Peay State University, Clarksville, Tennessee, USA.
Li S; Department of Dermatology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Hua L; Department of Dermatology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Cai H; Department of Forensic Medicine, Xuzhou Medical University, Xuzhou, Jiangsu, China.; Jiangsu Medical Engineering, Research Center of Gene Detection, Xuzhou, Jiangsu, China.
Li X; Department of Dermatology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.; Institute of Dermatology, Shanghai Academy of Traditional Chinese Medicine, Shanghai, China.
Pokaż więcej
Źródło :
Molecular carcinogenesis [Mol Carcinog] 2020 Nov; Vol. 59 (11), pp. 1292-1301. Date of Electronic Publication: 2020 Sep 13.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł :
SIRT2 modulates VEGFD-associated lymphangiogenesis by deacetylating EPAS1 in human head and neck cancer.
Autorzy :
Hu A; Department of Otolaryngology-Head and Neck Surgery, Gongli Hospital, Second Military Medical University, Shanghai, China.
Yang LY; Department of Otolaryngology-Head and Neck Surgery, Gongli Hospital, Second Military Medical University, Shanghai, China.
Liang J; Department of Otolaryngology-Head and Neck Surgery, Gongli Hospital, Second Military Medical University, Shanghai, China.
Lu D; Department of Otolaryngology-Head and Neck Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zhang JL; Department of Otolaryngology, Jinqiao Community Health Service Center, Shanghai, China.
Cao FF; Department of Sino-French Cooperative Central Lab, Gongli Hospital, Second Military Medical University, Shanghai, China.
Fu JY; Department of Otolaryngology-Head and Neck Surgery, Gongli Hospital, Second Military Medical University, Shanghai, China.
Dai WJ; Department of Otolaryngology-Head and Neck Surgery, Gongli Hospital, Second Military Medical University, Shanghai, China.
Zhang JF; Department of Otolaryngology-Head and Neck Surgery, Gongli Hospital, Second Military Medical University, Shanghai, China.
Pokaż więcej
Źródło :
Molecular carcinogenesis [Mol Carcinog] 2020 Nov; Vol. 59 (11), pp. 1280-1291. Date of Electronic Publication: 2020 Sep 23.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł :
Novel mechanistic targets of forkhead box Q1 transcription factor in human breast cancer cells.
Autorzy :
Kim SH; Department of Pharmacology & Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Hahm ER; Department of Pharmacology & Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Singh KB; Department of Pharmacology & Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Singh SV; Department of Pharmacology & Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Pokaż więcej
Źródło :
Molecular carcinogenesis [Mol Carcinog] 2020 Oct; Vol. 59 (10), pp. 1116-1128. Date of Electronic Publication: 2020 Aug 05.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Gene Expression Regulation, Neoplastic*
Biomarkers, Tumor/*metabolism
Breast Neoplasms/*pathology
Forkhead Transcription Factors/*metabolism
Apoptosis ; Biomarkers, Tumor/genetics ; Breast Neoplasms/genetics ; Breast Neoplasms/metabolism ; Cell Cycle ; Cell Movement ; Cell Proliferation ; Female ; Forkhead Transcription Factors/genetics ; Gene Expression Profiling ; Humans ; Interleukin-1alpha/genetics ; Interleukin-1alpha/metabolism ; Interleukin-8/genetics ; Interleukin-8/metabolism ; Prognosis ; Tumor Cells, Cultured ; Vascular Endothelial Growth Factor A/genetics ; Vascular Endothelial Growth Factor A/metabolism
Czasopismo naukowe
Tytuł :
Cytoprotective autophagy induction by withaferin A in prostate cancer cells involves GABARAPL1.
Autorzy :
Hahm ER; Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Singh SV; Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Pokaż więcej
Źródło :
Molecular carcinogenesis [Mol Carcinog] 2020 Oct; Vol. 59 (10), pp. 1105-1115. Date of Electronic Publication: 2020 Aug 03.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Autophagy*
Cytoprotection*
Adaptor Proteins, Signal Transducing/*metabolism
Biomarkers, Tumor/*metabolism
Gene Expression Regulation, Neoplastic/*drug effects
Microtubule-Associated Proteins/*metabolism
Prostatic Neoplasms/*drug therapy
Withanolides/*pharmacology
Adaptor Proteins, Signal Transducing/genetics ; Apoptosis ; Biomarkers, Tumor/genetics ; Cell Proliferation ; Gene Expression Profiling ; Humans ; Male ; Microtubule-Associated Proteins/genetics ; Prognosis ; Prostatic Neoplasms/metabolism ; Prostatic Neoplasms/pathology ; Tumor Cells, Cultured
Czasopismo naukowe
Tytuł :
MYC-binding lncRNA EPIC1 promotes AKT-mTORC1 signaling and rapamycin resistance in breast and ovarian cancer.
Autorzy :
Wang Y; Department of Pharmaceutical Sciences, Center for Pharmacogenetics, University of Pittsburgh, Pittsburgh, Pennsylvania.
Zhang M; Department of Pharmaceutical Sciences, Center for Pharmacogenetics, University of Pittsburgh, Pittsburgh, Pennsylvania.
Wang Z; Department of Pharmaceutical Sciences, Center for Pharmacogenetics, University of Pittsburgh, Pittsburgh, Pennsylvania.
Guo W; Department of Pharmaceutical Sciences, Center for Pharmacogenetics, University of Pittsburgh, Pittsburgh, Pennsylvania.
Yang D; Department of Pharmaceutical Sciences, Center for Pharmacogenetics, University of Pittsburgh, Pittsburgh, Pennsylvania.; UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, Pennsylvania.; Department of Computational and Systems Biology, University of Pittsburgh, Pittsburgh, Pennsylvania.
Pokaż więcej
Źródło :
Molecular carcinogenesis [Mol Carcinog] 2020 Oct; Vol. 59 (10), pp. 1188-1198. Date of Electronic Publication: 2020 Aug 18.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug Resistance, Neoplasm*
Breast Neoplasms/*drug therapy
Mechanistic Target of Rapamycin Complex 1/*metabolism
Ovarian Neoplasms/*drug therapy
Proto-Oncogene Proteins c-akt/*metabolism
Proto-Oncogene Proteins c-myc/*metabolism
RNA, Long Noncoding/*metabolism
Sirolimus/*pharmacology
Antibiotics, Antineoplastic/pharmacology ; Apoptosis ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Breast Neoplasms/metabolism ; Breast Neoplasms/pathology ; Cell Proliferation ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Mechanistic Target of Rapamycin Complex 1/genetics ; Ovarian Neoplasms/metabolism ; Ovarian Neoplasms/pathology ; Proto-Oncogene Proteins c-akt/genetics ; Proto-Oncogene Proteins c-myc/genetics ; RNA, Long Noncoding/genetics ; Tumor Cells, Cultured
Czasopismo naukowe
Tytuł :
SALL4 promotes tumor progression in breast cancer by targeting EMT.
Autorzy :
Chen T; Department of Applied Biology and Chemical Technology, State Key Laboratory of Chemical Biology and Drug Discovery, The Hong Kong Polytechnic University, Hong Kong SAR.
Tsang JYS; Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Sha Tin, Hong Kong SAR.
Su XC; Department of Applied Biology and Chemical Technology, State Key Laboratory of Chemical Biology and Drug Discovery, The Hong Kong Polytechnic University, Hong Kong SAR.
Li P; Department of Applied Biology and Chemical Technology, State Key Laboratory of Chemical Biology and Drug Discovery, The Hong Kong Polytechnic University, Hong Kong SAR.
Sun WQ; Department of Applied Biology and Chemical Technology, State Key Laboratory of Chemical Biology and Drug Discovery, The Hong Kong Polytechnic University, Hong Kong SAR.
Wong ILK; Department of Applied Biology and Chemical Technology, State Key Laboratory of Chemical Biology and Drug Discovery, The Hong Kong Polytechnic University, Hong Kong SAR.
Choy KY; Department of Applied Biology and Chemical Technology, State Key Laboratory of Chemical Biology and Drug Discovery, The Hong Kong Polytechnic University, Hong Kong SAR.
Yang Q; Department of Applied Biology and Chemical Technology, State Key Laboratory of Chemical Biology and Drug Discovery, The Hong Kong Polytechnic University, Hong Kong SAR.
Tse GMK; Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Sha Tin, Hong Kong SAR.
Chan TH; Department of Applied Biology and Chemical Technology, State Key Laboratory of Chemical Biology and Drug Discovery, The Hong Kong Polytechnic University, Hong Kong SAR.; Department of Chemistry, McGill University, Montreal, Quebec, Canada.
Chow LMC; Department of Applied Biology and Chemical Technology, State Key Laboratory of Chemical Biology and Drug Discovery, The Hong Kong Polytechnic University, Hong Kong SAR.
Pokaż więcej
Źródło :
Molecular carcinogenesis [Mol Carcinog] 2020 Oct; Vol. 59 (10), pp. 1209-1226. Date of Electronic Publication: 2020 Aug 24.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Epithelial-Mesenchymal Transition*
Gene Expression Regulation, Neoplastic*
Biomarkers, Tumor/*metabolism
Lung Neoplasms/*secondary
Transcription Factors/*metabolism
Triple Negative Breast Neoplasms/*pathology
Adult ; Aged ; Aged, 80 and over ; Animals ; Apoptosis ; Biomarkers, Tumor/genetics ; Cell Movement ; Cell Proliferation ; Female ; Humans ; Lung Neoplasms/genetics ; Lung Neoplasms/metabolism ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; Middle Aged ; Neoplasm Invasiveness ; Prognosis ; Transcription Factors/genetics ; Triple Negative Breast Neoplasms/genetics ; Triple Negative Breast Neoplasms/metabolism ; Tumor Cells, Cultured ; Xenograft Model Antitumor Assays ; Young Adult
Czasopismo naukowe
Tytuł :
IL-1RN gene polymorphisms reduces thyroid cancer risk in Chinese Han population.
Autorzy :
Li H; Department of Otolaryngology and Head Neck, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Wu Y; Department of Operation, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Zhao R; Department of Otolaryngology and Head Neck, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Chen X; Department of Otolaryngology and Head Neck, Baoji Central Hospital, Baoji, Shaanxi, China.
Ren W; Department of Otolaryngology and Head Neck, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Li H; Department of Otolaryngology and Head Neck, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Han P; Department of Otolaryngology and Head Neck, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Shao Y; Department of Otolaryngology and Head Neck, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Wang J; Department of Surgical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Pokaż więcej
Źródło :
Molecular carcinogenesis [Mol Carcinog] 2020 Oct; Vol. 59 (10), pp. 1140-1146. Date of Electronic Publication: 2020 Aug 13.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Asian Continental Ancestry Group/*genetics
Biomarkers, Tumor/*genetics
Interleukin 1 Receptor Antagonist Protein/*genetics
Thyroid Neoplasms/*genetics
Case-Control Studies ; China/epidemiology ; Female ; Follow-Up Studies ; Genetic Predisposition to Disease ; Genotype ; Humans ; Male ; Middle Aged ; Polymorphism, Single Nucleotide ; Prognosis ; Thyroid Neoplasms/epidemiology ; Thyroid Neoplasms/pathology
Czasopismo naukowe
Tytuł :
lncRNA CERS6-AS1 as ceRNA promote cell proliferation of breast cancer by sponging miR-125a-5p to upregulate BAP1 expression.
Autorzy :
Yan L; Anhui Provincial Key Laboratory of Biological Macro-molecules Research, Wannan Medical College, Wuhu, Anhui, China.
Li K; Department of Clinical Diagnostics, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, Anhui, China.
Feng Z; Anhui Provincial Key Laboratory of Biological Macro-molecules Research, Wannan Medical College, Wuhu, Anhui, China.
Zhang Y; Department of Clinical Medicine, The First College of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong, China.
Han R; Anhui Provincial Key Laboratory of Biological Macro-molecules Research, Wannan Medical College, Wuhu, Anhui, China.
Ma J; Anhui Provincial Key Laboratory of Biological Macro-molecules Research, Wannan Medical College, Wuhu, Anhui, China.
Zhang J; Department of Clinical Diagnostics, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, Anhui, China.
Wu X; Anhui Provincial Key Laboratory of Biological Macro-molecules Research, Wannan Medical College, Wuhu, Anhui, China.
Liu H; Anhui Provincial Key Laboratory of Biological Macro-molecules Research, Wannan Medical College, Wuhu, Anhui, China.
Jiang Y; Anhui Provincial Key Laboratory of Biological Macro-molecules Research, Wannan Medical College, Wuhu, Anhui, China.
Zhang Y; Anhui Provincial Key Laboratory of Biological Macro-molecules Research, Wannan Medical College, Wuhu, Anhui, China.
Zhu Y; Department of Clinical Diagnostics, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, Anhui, China.
Pokaż więcej
Źródło :
Molecular carcinogenesis [Mol Carcinog] 2020 Oct; Vol. 59 (10), pp. 1199-1208. Date of Electronic Publication: 2020 Aug 18.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cell Proliferation*
Breast Neoplasms/*pathology
Membrane Proteins/*antagonists & inhibitors
MicroRNAs/*genetics
Oligonucleotides, Antisense/*genetics
RNA, Long Noncoding/*genetics
Sphingosine N-Acyltransferase/*antagonists & inhibitors
Tumor Suppressor Proteins/*metabolism
Ubiquitin Thiolesterase/*metabolism
Animals ; Apoptosis ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Breast Neoplasms/genetics ; Breast Neoplasms/metabolism ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Membrane Proteins/genetics ; Mice ; Mice, Nude ; Sphingosine N-Acyltransferase/genetics ; Tumor Cells, Cultured ; Tumor Suppressor Proteins/genetics ; Ubiquitin Thiolesterase/genetics ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł :
LncRNA UCA1 maintains the low-tumorigenic and nonmetastatic status by stabilizing E-cadherin in primary prostate cancer cells.
Autorzy :
Zhao X; Department of Biochemistry and Molecular Cell Biology, Shanghai Key Laboratory of Tumor Microenvironment and Inflammation, State Key Laboratory of Oncogenes and Related Genes, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Wang Y; Department of Biochemistry and Molecular Cell Biology, Shanghai Key Laboratory of Tumor Microenvironment and Inflammation, State Key Laboratory of Oncogenes and Related Genes, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
He J; Department of Biochemistry and Molecular Cell Biology, Shanghai Key Laboratory of Tumor Microenvironment and Inflammation, State Key Laboratory of Oncogenes and Related Genes, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Deng R; Department of Biochemistry and Molecular Cell Biology, Shanghai Key Laboratory of Tumor Microenvironment and Inflammation, State Key Laboratory of Oncogenes and Related Genes, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Huang X; Faculty of Health of Sciences, Institute of Translational Medicine, University of Macau, Macau SAR, China.
Guo Y; Department of Biochemistry and Molecular Cell Biology, Shanghai Key Laboratory of Tumor Microenvironment and Inflammation, State Key Laboratory of Oncogenes and Related Genes, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Li L; Department of Biochemistry and Molecular Cell Biology, Shanghai Key Laboratory of Tumor Microenvironment and Inflammation, State Key Laboratory of Oncogenes and Related Genes, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Xie R; Faculty of Health of Sciences, Institute of Translational Medicine, University of Macau, Macau SAR, China.
Yu J; Department of Biochemistry and Molecular Cell Biology, Shanghai Key Laboratory of Tumor Microenvironment and Inflammation, State Key Laboratory of Oncogenes and Related Genes, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Basic Clinical Research Center, School of Medicine, Renji Hospital, Shanghai Jiao Tong University, Shanghai, China.
Pokaż więcej
Źródło :
Molecular carcinogenesis [Mol Carcinog] 2020 Oct; Vol. 59 (10), pp. 1174-1187. Date of Electronic Publication: 2020 Aug 17.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Gene Expression Regulation, Neoplastic*
Antigens, CD/*metabolism
Biomarkers, Tumor/*metabolism
Cadherins/*metabolism
MicroRNAs/*genetics
Prostatic Neoplasms/*pathology
RNA, Long Noncoding/*genetics
Animals ; Antigens, CD/genetics ; Apoptosis ; Biomarkers, Tumor/genetics ; Cadherins/genetics ; Cell Proliferation ; Humans ; Male ; Mice ; Mice, SCID ; Prostatic Neoplasms/genetics ; Prostatic Neoplasms/metabolism ; Tumor Cells, Cultured ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł :
Bitter melon juice intake with gemcitabine intervention circumvents resistance to gemcitabine in pancreatic patient-derived xenograft tumors.
Autorzy :
Dhar D; Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Denver-Anschutz Medical Campus, Aurora, Colorado.
Raina K; Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Denver-Anschutz Medical Campus, Aurora, Colorado.; Department of Pharmaceutical Sciences, South Dakota State University, Brookings, South Dakota.
Kumar D; Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Denver-Anschutz Medical Campus, Aurora, Colorado.
Wempe MF; Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Denver-Anschutz Medical Campus, Aurora, Colorado.
Bagby SM; Division of Medical Oncology, School of Medicine, University of Colorado Denver-Anschutz Medical Campus, Aurora, Colorado.
Pitts TM; Division of Medical Oncology, School of Medicine, University of Colorado Denver-Anschutz Medical Campus, Aurora, Colorado.
Orlicky DJ; Department of Pathology, University of Colorado Denver-Anschutz Medical Campus, Aurora, Colorado.
Agarwal C; Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Denver-Anschutz Medical Campus, Aurora, Colorado.
Messersmith WA; Division of Medical Oncology, School of Medicine, University of Colorado Denver-Anschutz Medical Campus, Aurora, Colorado.; University of Colorado Cancer Center, University of Colorado Denver-Anschutz Medical Campus, Aurora, Colorado.
Agarwal R; Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Denver-Anschutz Medical Campus, Aurora, Colorado.; University of Colorado Cancer Center, University of Colorado Denver-Anschutz Medical Campus, Aurora, Colorado.
Pokaż więcej
Źródło :
Molecular carcinogenesis [Mol Carcinog] 2020 Oct; Vol. 59 (10), pp. 1227-1240. Date of Electronic Publication: 2020 Aug 20.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Disease Models, Animal*
Carcinoma, Pancreatic Ductal/*drug therapy
Deoxycytidine/*analogs & derivatives
Drug Resistance, Neoplasm/*drug effects
Momordica charantia/*chemistry
Pancreatic Neoplasms/*drug therapy
Plant Extracts/*pharmacology
Animals ; Antimetabolites, Antineoplastic/pharmacology ; Apoptosis ; Carcinoma, Pancreatic Ductal/pathology ; Cell Proliferation ; Deoxycytidine/pharmacology ; Female ; Humans ; Mice ; Mice, Nude ; Neoplasm Invasiveness ; Pancreatic Neoplasms/pathology ; Tumor Cells, Cultured ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł :
SOX6 represses tumor growth of clear cell renal cell carcinoma by HMG domain-dependent regulation of Wnt/β-catenin signaling.
Autorzy :
Chen L; Department of Urology, First Affiliated Hospital of Nanchang University, Nanchang, China.
Xie Y; Department of Urology, First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Ma X; Department of Urology, Chinese PLA General Hospital, Beijing, China.
Zhang Y; Department of Urology, Chinese PLA General Hospital, Beijing, China.
Li X; Department of Urology, Chinese PLA Air Force General Hospital, Beijing, China.
Zhang F; Department of Urology, Chinese PLA General Hospital, Beijing, China.
Gao Y; Department of Urology, Chinese PLA General Hospital, Beijing, China.
Fan Y; Department of Urology, Chinese PLA General Hospital, Beijing, China.
Gu L; Department of Urology, Chinese PLA General Hospital, Beijing, China.
Wang L; Department of Urology, Chinese PLA General Hospital, Beijing, China.
Zhang X; Department of Urology, Chinese PLA General Hospital, Beijing, China.
Fu B; Department of Urology, First Affiliated Hospital of Nanchang University, Nanchang, China.
Pokaż więcej
Źródło :
Molecular carcinogenesis [Mol Carcinog] 2020 Oct; Vol. 59 (10), pp. 1159-1173. Date of Electronic Publication: 2020 Aug 14.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
HMG-Box Domains*
Biomarkers, Tumor/*metabolism
Carcinoma, Renal Cell/*pathology
Kidney Neoplasms/*pathology
SOXD Transcription Factors/*metabolism
Wnt1 Protein/*metabolism
beta Catenin/*metabolism
Animals ; Apoptosis ; Biomarkers, Tumor/genetics ; Carcinoma, Renal Cell/genetics ; Carcinoma, Renal Cell/metabolism ; Cell Proliferation ; Cell Transformation, Neoplastic ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Kidney Neoplasms/genetics ; Kidney Neoplasms/metabolism ; Male ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; Middle Aged ; Prognosis ; SOXD Transcription Factors/genetics ; Survival Rate ; Tumor Cells, Cultured ; Wnt1 Protein/genetics ; Xenograft Model Antitumor Assays ; beta Catenin/genetics
Czasopismo naukowe
Tytuł :
Analysis of circulating breast cancer cell heterogeneity and interactions with peripheral blood mononuclear cells.
Autorzy :
Brechbuhl HM; Department of Medicine, Division of Medical Oncology, University of Colorado, Aurora, Colorado.
Vinod-Paul K; Department of Medicine, Division of Medical Oncology, University of Colorado, Aurora, Colorado.
Gillen AE; Biochemistry and Molecular Genetics, University of Colorado, Aurora, Colorado.
Kopin EG; Department of Medicine, Division of Medical Oncology, University of Colorado, Aurora, Colorado.
Gibney K; Department of Medicine, Cancer Center, University of Colorado, Aurora, Colorado.
Elias AD; Department of Medicine, Division of Medical Oncology, University of Colorado, Aurora, Colorado.
Hayashi M; Department Pediatrics, University of Colorado, Aurora, Colorado.
Sartorius CA; Department of Pathology, University of Colorado, Aurora, Colorado.
Kabos P; Department of Medicine, Division of Medical Oncology, University of Colorado, Aurora, Colorado.
Pokaż więcej
Źródło :
Molecular carcinogenesis [Mol Carcinog] 2020 Oct; Vol. 59 (10), pp. 1129-1139. Date of Electronic Publication: 2020 Aug 21.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Epithelial-Mesenchymal Transition*
Biomarkers, Tumor/*metabolism
Breast Neoplasms/*pathology
Leukocytes, Mononuclear/*pathology
Neoplastic Cells, Circulating/*pathology
Breast Neoplasms/blood ; Female ; Humans ; Prognosis ; Receptor, ErbB-2/metabolism ; Receptors, Estrogen/metabolism ; Receptors, Progesterone/metabolism ; Tumor Cells, Cultured
Czasopismo naukowe
Tytuł :
Upregulation of secreted phosphoprotein 1 affects malignant progression, prognosis, and resistance to cetuximab via the KRAS/MEK pathway in head and neck cancer.
Autorzy :
Liu K; School of Medicine, Southeast University, Nanjing, Jiangsu, China.; Department of Otolaryngology Head and Neck Surgery, BenQ Medical Center, The Affiliated BenQ Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.; Center of Yu Zhenkun Otolaryngology Head and Neck Surgery, BenQ Medical Center, The Affiliated BenQ Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Hu H; School of Medicine, Southeast University, Nanjing, Jiangsu, China.; Department of Otolaryngology Head and Neck Surgery, BenQ Medical Center, The Affiliated BenQ Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.; Center of Yu Zhenkun Otolaryngology Head and Neck Surgery, BenQ Medical Center, The Affiliated BenQ Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Jiang H; School of Medicine, Southeast University, Nanjing, Jiangsu, China.; Department of Otolaryngology Head and Neck Surgery, BenQ Medical Center, The Affiliated BenQ Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.; Center of Yu Zhenkun Otolaryngology Head and Neck Surgery, BenQ Medical Center, The Affiliated BenQ Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Liu C; Department of Radiology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zhang H; Department of Otolaryngology Head and Neck Surgery, BenQ Medical Center, The Affiliated BenQ Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.; Center of Yu Zhenkun Otolaryngology Head and Neck Surgery, BenQ Medical Center, The Affiliated BenQ Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Gong S; Department of Otolaryngology Head and Neck Surgery, BenQ Medical Center, The Affiliated BenQ Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.; Center of Yu Zhenkun Otolaryngology Head and Neck Surgery, BenQ Medical Center, The Affiliated BenQ Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Wei D; Department of Otorhinolaryngology, Key Laboratory of Otolaryngology, Qilu Hospital, Shandong University, NHFPC (Shandong University), Jinan, Shandong, China.
Yu Z; School of Medicine, Southeast University, Nanjing, Jiangsu, China.; Department of Otolaryngology Head and Neck Surgery, BenQ Medical Center, The Affiliated BenQ Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.; Center of Yu Zhenkun Otolaryngology Head and Neck Surgery, BenQ Medical Center, The Affiliated BenQ Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Pokaż więcej
Źródło :
Molecular carcinogenesis [Mol Carcinog] 2020 Oct; Vol. 59 (10), pp. 1147-1158. Date of Electronic Publication: 2020 Aug 17.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug Resistance, Neoplasm*
Biomarkers, Tumor/*metabolism
Cetuximab/*pharmacology
Head and Neck Neoplasms/*pathology
MAP Kinase Kinase 1/*metabolism
Osteopontin/*metabolism
Proto-Oncogene Proteins p21(ras)/*metabolism
Animals ; Antineoplastic Agents, Immunological/pharmacology ; Apoptosis ; Biomarkers, Tumor/genetics ; Cell Movement ; Cell Proliferation ; Disease Progression ; Female ; Gene Expression Regulation, Neoplastic ; Head and Neck Neoplasms/drug therapy ; Head and Neck Neoplasms/genetics ; Head and Neck Neoplasms/metabolism ; Humans ; MAP Kinase Kinase 1/genetics ; Mice ; Mice, Nude ; Neoplasm Invasiveness ; Osteopontin/genetics ; Prognosis ; Proto-Oncogene Proteins p21(ras)/genetics ; Signal Transduction ; Squamous Cell Carcinoma of Head and Neck/drug therapy ; Squamous Cell Carcinoma of Head and Neck/genetics ; Squamous Cell Carcinoma of Head and Neck/metabolism ; Squamous Cell Carcinoma of Head and Neck/pathology ; Tumor Cells, Cultured ; Xenograft Model Antitumor Assays
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies